Research Article
Disease Extent ≥4 cm Is a Prognostic Marker of Local Recurrence in T1-2 Breast Cancer
Table 2
A disease extent ≥4 cm is the only significant prognostic marker for an increased risk of local recurrence.
| | HR1 | (99% CI2) | -value |
| Disease extent ≥4 cm | 11.099 | (1.264–97.464) | 0.004 | Size ≥15 mm or <15 mm | 2.699 | (0.392–18.596) | 0.185 | Grade of in situ lesion | 0.350 | (0.051–2.403) | 0.160 | Grade of invasive lesion | 1.584 | (0.165–15.165) | 0.600 | Radiotherapy | 0.273 | (0.021–3.577) | 0.194 | Hormonal therapy | 0.000 | (0.000–<100000) | 0.959 | Chemotherapy | 2.618 | (0.082–83.180 | 0.474 | Estrogen receptor status | 462417 | (0.000–<100000) | 0.982 | Progesterone receptor status | 0.568 | (0.057–5.657) | 0.526 | Age | 0.958 | (0.868–1.058) | 0.267 |
|
|
1Hazard Ratio, 2Confidence Interval.
|